Revenue for Incyte (INCY)
According to Incyte's latest reported financial statements, the company's current revenue (TTM) is $5.36B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
INCY
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$5.36B
YoY change
+21.2%
5Y CAGR
+14.0%
Peak year (2025)
$5.14B
Cumulative revenue
$32.08B
Revenue history chart for Incyte (INCY) from 1993 to 2025
Revenue history table for Incyte (INCY) from 1993 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $5.14B | +21.2% | ||
| 2024 | $4.24B | +14.8% | ||
| 2023 | $3.70B | +8.9% | ||
| 2022 | $3.39B | +13.7% | ||
| 2021 | $2.99B | +12.0% | ||
| 2020 | $2.67B | +23.5% | ||
| 2019 | $2.16B | +14.7% | ||
| 2018 | $1.88B | +22.5% | ||
| 2017 | $1.54B | +38.9% | ||
| 2016 | $1.11B | +46.7% | ||
| 2015 | $753.75M | +47.4% | ||
| 2014 | $511.50M | +44.1% | ||
| 2013 | $354.95M | +19.5% | ||
| 2012 | $297.06M | +214.5% | ||
| 2011 | $94.45M | -44.4% | ||
| 2010 | $169.88M | +1733.5% | ||
| 2009 | $9.27M | +136.4% | ||
| 2008 | $3.92M | -88.6% | ||
| 2007 | $34.44M | +24.6% | ||
| 2006 | $27.64M | +252.3% | ||
| 2005 | $7.85M | -44.5% | ||
| 2004 | $14.15M | -70.0% | ||
| 2003 | $47.09M | -53.7% | ||
| 2002 | $101.61M | -53.7% | ||
| 2001 | $219.26M | +12.9% | ||
| 2000 | $194.17M | +23.7% | ||
| 1999 | $157.00M | +16.5% | ||
| 1998 | $134.80M | +52.5% | ||
| 1997 | $88.40M | +111.5% | ||
| 1996 | $41.80M | +242.6% | ||
| 1995 | $12.20M | +6000.0% | ||
| 1994 | $200,000 | -33.3% | ||
| 1993 | $300,000 | — |
Revenue values are taken from Incyte's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual revenue for Incyte (INCY) came in at $5.14B – grew 21.2% year-over-year.
Across 2020–2025 (5 years), Incyte revenue produced a CAGR of +14.0% – sustaining 14 straight years of year-over-year growth.
Across the available history, revenue reached its high of $5.14B in 2025 and its low of $200,000 in 1994.
Among 8 Healthcare peers, Incyte (INCY) ranks 9th; the peer median for revenue is $65.09B.
Incyte Revenue by Year
Incyte Revenue 2025: $5.14B
Incyte revenue in 2025 was $5.14B, grew 21.2% from 2024. This figure represents the highest annual value in the available history.
Incyte Revenue 2024: $4.24B
Incyte revenue in 2024 was $4.24B, grew 14.8% from 2023.
Incyte Revenue 2023: $3.70B
Incyte revenue in 2023 was $3.70B, grew 8.9% from 2022.
Incyte Revenue 2022: $3.39B
Incyte revenue in 2022 was $3.39B, grew 13.7% from 2021.
Incyte Revenue 2021: $2.99B
Incyte revenue in 2021 was $2.99B.
See more financial history for Incyte (INCY).
Sector peers — Revenue
Companies in the same sector as Incyte, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Incyte's revenue?
- Latest reported revenue for Incyte (INCY) is $5.36B (period ending March 31, 2026).
How has Incyte revenue changed year-over-year?
- Incyte (INCY) revenue changed +21.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Incyte revenue?
- Incyte (INCY) revenue compound annual growth rate is +14.0% over the most recent 5 years available.
When did Incyte revenue hit its highest annual value?
- Incyte revenue reached its highest annual value of $5.14B in 2025.
What was Incyte revenue in 2024?
- Incyte (INCY) revenue in 2024 was $4.24B.
What was Incyte revenue in 2025?
- Incyte (INCY) revenue in 2025 was $5.14B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INCY Overview
Company profile, financial tools, and key metrics
INCY Revenue Counter
Earns $163.03 every second. See per minute, hour, and day.
INCY Earnings Counter
Earns $40.80 per second net profit. See per minute, hour, and day.
INCY Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
INCY What If Invested
What if you had invested $1,000? See historical returns from any date.
INCY How It Makes Money
Discover visual breakdown of $5.14B in revenue — where it comes from and where it goes.
INCY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INCY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INCY Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
INCY Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
INCY Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.